|
Home : Unsafe Drugs : Avandia : Newsfeeds : Researchers Suggest Role for Hypothalamic PPAR-gamma in Diabetes Drug-Related Weight Gain Researchers Suggest Role for Hypothalamic PPAR-gamma in Diabetes Drug-Related Weight Gain
PPAR-? is also the target of TZDs including rosiglitazone, for the treatment of type 2 diabetes, and chronic peripheral administration of such drugs improves glycemic control, but at the expense of increased caloric intake, body weight and body fat gain.
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




